In a groundbreaking achievement, scientists have successfully cloned a rhesus monkey (Macaca mulatta) that has now lived into adulthood for over two years. This landmark accomplishment, detailed in Nature Communications, distinguishes itself as the first-ever successful cloning of this primate species. Utilizing an innovative approach, researchers replaced the placenta of the cloned embryo with those from embryos produced through in vitro fertilization (IVF), resulting in enhanced developmental success and fewer defects. This technique holds significant promise for advancing drug testing and behavioral research using cloned primates. The breakthrough opens avenues for creating genetically uniform monkey populations for drug efficacy studies. This development is crucial for healthcare professionals in delivering evidence-based addiction treatment and holds implications for saving lives and preventing overdose deaths. The study challenges the practice of enforcing cannabis abstinence for opioid use disorder treatment eligibility, emphasizing the need for individualized treatment approaches. With cannabis now legally recognized for medicinal use in many states, the study advocates for a more nuanced understanding of its impact on opioid addiction and encourages further clinical trials to assess cannabis’s effectiveness in addressing symptoms of opioid addiction.